U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry UNKNOWN
Molecular Formula C34H38N2O4
Molecular Weight 538.6765
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NAFIVERINE

SMILES

CC(C(=O)OCCN1CCN(CCOC(=O)C(C)C2=C3C=CC=CC3=CC=C2)CC1)C4=CC=CC5=CC=CC=C45

InChI

InChIKey=ZLFQARCCMWUSQE-UHFFFAOYSA-N
InChI=1S/C34H38N2O4/c1-25(29-15-7-11-27-9-3-5-13-31(27)29)33(37)39-23-21-35-17-19-36(20-18-35)22-24-40-34(38)26(2)30-16-8-12-28-10-4-6-14-32(28)30/h3-16,25-26H,17-24H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C34H38N2O4
Molecular Weight 538.6765
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Nafiverinel, N,N'-di[a-(1-naphthy1)propionyloxy-2-ethyllpiperazine, is a new synthetic antispasmodic, which shows low toxicity and a high myolytic activity on the smooth muscles of the ileum, uterus and coronary vessels.

Approval Year

Sample Use Guides

In Vivo Use Guide
300 mg three times every 2 hr
Route of Administration: Intramuscular
Substance Class Chemical
Record UNII
WLT400RC9Q
Record Status Validated (UNII)
Record Version